Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49

Journal of Immunology

Volumn 166, Issue 6, 2001, Pages 3771-3779

  Toyama Sorimachi, N ^a   Taguchi, Y ^a   Yagita, H ^a   Kitamura, F ^a   Kawasaki, A ^a   Koyasu, S ^a   Karasuyama, H ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; LECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ARTICLE; CELL SELECTION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; IMMUNOLOGICAL TOLERANCE; MOUSE; NATURAL KILLER CELL; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TARGET CELL;

EID: 0035869420     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.6.3771     Document Type: Article

References (64)

1. The role of natural killer cells in innate resistance to infection
2. The role of natural killer cells in host-parasite interactions
3. Development of human T and natural killer cells
4. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy
5. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice
6. - bone marrow in chimeric mice
7. In search of the 'missing self': MHC molecules and NK cell recognition
8. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors
9. Major histocompatibility of complex class I-specific receptors on human natural killer and T lymphocytes
10. Killer cell inhibitory receptors: Diversity, specificity, and function
11. The Ly-49 family: Genes, proteins and recognition of class I MHC
12. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors
13. Natural killer receptors
14. Follow the leader: NK cell receptors for classical and nonclassical MHC class I
15. The Ly-49 and NKR-PI gene families encoding lectin-like receptors on natural killer cells: The NK gene complex
16. Natural killer cell receptors
17. The CD94/NKG2 C-type lectin receptor complex
18. Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E
19. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells
20. Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells
21. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
22. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
23. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
24. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHPphosphatase recruitment to tyrosine-phosphorylated NKG2-A: Evidence for receptor function in heterologous transfection
25. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9
26. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide
27. Signal sequences stop killer cells
28. Cytotoxic lymphocyte recognition of HLA-E: Utilizing a nonclassical window to peer into classical MHC
29. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen
30. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotype
31. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimer of CD94 and NKG2 subunits
32. Association of DAP12 with activating CD94/NKG2C NK cell receptors
33. An activating immunoreceptor complex formed by NKG2D and DAP10
34. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
35. b
36. b by putative activating receptors CD94/NKG2C and CD94/ NKG2E on mouse natural killer cells
37. MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity
38. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
39. Cortisone-induced cleft palate in the brachymorphic mouse
40. Generation of 2 new mouse myeloma cell line "PAI" and "PAI-O" for hybridoma production
41. Growth autonomy and tumorigenicity of interleukin 6-dependent B cells transfected with interleukin 6 cDNA
42. Molecular cloning of mouse NKG2A and C
43. Cloning of murine NKG2A, B and C: Second family of C-type lectin receptors on murine NK cells
44. The Igα/Igα heterodimer on μ-negative proB cells is competent for transducing signals to induce early B cell differentiation
45. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors
46. -/- mice: Roles of both IL-2 and IL-15 in CD8αα IEL development
47. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen
48. Endogenous generation and presentation of the ovalbumin
49. - cells: A possible mechanism of tolerance during NK cell development
50. Stochastic acquisition of Qa-receptors during the development of fetal NK cells in vitro accounts in part but not in whole for the ability of these cells to distinguish between class I-sufficient and class I-deficient targets
51. Fetal mouse NK cell clones are deficient in Ly-49 expression, share a common broad lytic specificity, and undergo continuous and extensive diversification in vitro
52. Phenotypic and functional characterization of long-lived NK cell lines of different maturational status obtained from mouse fetal liver
53. lo target cells: Evidence for a Ly-49-independent negative signaling receptor
54. Cloning of minimally divergent allelic forms of the natural killer (NK) receptor Ly-49C, differentially controlled by host genes in the MHC and NK gene complexes
55. Altered expression of Ly-49 inhibitory receptors on natural killer cells from MHC class I-deficient mice
56. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand
57. The Qa molecule binds to a large subpopulation of murine NK cells
58. Nonstochastic coexpression of activation receptors on murine natural killer cells
59. The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts
60. Structual and functional characteristics of the class IB molecule, Qa-I
61. Tolerance and alloreactivity of the Ly49D subset of murine NK cells
62. Acquisition of Ly49 receptor expression by developing natural killer cells
63. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes
64. CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients